OnCoCross Co (382150.KQ) Stock Price

OnCoCross Co Price

CLOSED
3,670.00
​
Market closed

Revenue has compounded at 35.1% per year over the past 3 years to 370.46 M KRW. OnCoCross Co's net margin stands at -2,410.2%, up from -6,791.6% several years earlier.

OnCoCross Co stock price

Access this data via the Eulerpool API

OnCoCross Co business model & stock analysis

OnCoCross Co Ltd is a KR-based company operating in industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-12-18. OnCoCross Co Ltd is a Korea-based company primarily engaged in the new drug research and development business. The firm mainly develops artificial intelligence (AI) new drug development platform based on its original technology which analyzing changes in gene expression data (Transcriptome) due to drug administration or disease occurrence and using AI to match the optimal disease and treatment. The firm mainly develops treatments for rare diseases, cancer, dementia and other intractable diseases.

Frequently asked questions about OnCoCross Co

Converted at the current exchange rate, the OnCoCross Co share trades at 2.44 EUR (3,670.00 KRW).

The revenue cannot currently be calculated for OnCoCross Co.

The profit cannot currently be calculated for OnCoCross Co.

The P/E ratio cannot be calculated for OnCoCross Co at the moment.

The P/S cannot be calculated for OnCoCross Co currently.

The Eulerpool Quality Score for OnCoCross Co is 3/10.

The ISIN of OnCoCross Co is KR7382150001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of OnCoCross Co is 382150.KQ. The ticker symbol is used to trade OnCoCross Co shares on the stock exchange.

Fair ValueTerminal
3,156.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 18, 2024
ISIN
KR7382150001
Cusip
Y6S2FS108
Market capitalization
38.42 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.87
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-48.49 %
Last updated Oct 11, 2026, 4:32 AM

OnCoCross Co Peer Group

All fundamentals and in-depth analysis of OnCoCross Co

Our stock analysis for OnCoCross Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OnCoCross Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.